FDA Recalls Nystatin Oral Suspension Due to Subpotent Drug Levels
Pharmaceutical Associates, Inc. is recalling Nystatin Oral Suspension because it failed potency testing. Patients should consult their healthcare provider.
- Product
- NYSTATIN — NYSTATIN (NYSTATIN)
- Category
- Drug
- Distribution
- Distributed nationwide